Cancer Exercise App Trial for Post-Treatment Survivors

NIH registered a new clinical trial (NCT07535918) investigating the Cancer Exercise app as a home-based exercise intervention for cancer survivors who have completed treatment. The randomized controlled trial will enroll adults and randomly assign them to either the CEA group or usual care to assess effects on physical activity levels over 12 weeks. The trial is listed on ClinicalTrials.gov under the Using e-Technologies to Maximize Physical Activity After Cancer Treatment study.

For clinical researchers, trial sponsors, and healthcare providers, this registration signals an active investigation into digital health interventions for survivorship care. Organizations developing similar exercise or rehabilitation apps may want to monitor trial outcomes, as positive results could support evidence-based use of digital therapeutics in oncology survivorship programs. The trial involves no regulatory submission requirements for participating sites beyond standard IRB oversight.